Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Yamanouchi team identifies new P-selectin inhibitors for coronary artery disease

Feb. 7, 2005

Apoptosis inhibitors emerge from research at Vertex

Feb. 7, 2005

New antimitotic agents in early development at SCRAS

Feb. 7, 2005

New uses for adiponectin for heart failure described in a patent

Feb. 7, 2005

New compositions for controlled release of tolterodine claimed by Ranbaxy

Feb. 7, 2005

HMG-CoA reductase inhibitors identified by Ranbaxy team

Feb. 4, 2005

HER2 inhibitors developed at Pfizer

Feb. 4, 2005

Ranbaxy prepares novel formulations of antibiotic cefpodoxime with improved bioavailability

Feb. 4, 2005

Novel ACE inhibitors emerge from NicOx R&D

Feb. 4, 2005

New varenicline formulations for smoking cessation reported by Pfizer

Feb. 4, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...